Objectives:
1. To defi ne and describe the clinical syndrome of new-onset refractory status epileptics (NORSE);
2. To discuss the diagnostic and therapeutic approach to NORSE; and
3. To explore the potential role for early immunotherapy in the management of NORSE
Session date:
12/21/2017 - 3:00pm to 4:00pm CST
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Raisa Martinez MD